Novo Nordisk, the maker of Wegovy, has filed a lawsuit on Tuesday against competitor Eli Lilly alleging that its GLP-1 ...

By Maggie Fick and Michael Erman LONDON, July 21 (Reuters) - Novo Nordisk sued rival Eli Lilly in a U.S. federal court on ...

Novo Nordisk A/S sued Eli Lilly & Co., accusing its rival of misleading advertising as competition in the U.S. market for ...

By Maggie Fick LONDON, July 21 (Reuters) - Novo Nordisk said on Tuesday it was suing rival Eli Lilly in U.S. federal court, ...

Drugmaker Novo Nordisk sued rival Eli Lilly on Tuesday, accusing the company of false advertising over the performance of its ...

Eli Lilly has struck a deal to buy mental-health-focused AtaiBeckley for an initial $2.8 billion, continuing the drugmaker’s ...

Eli Lilly has struck a deal to buy psychedelic drug developer AtaiBeckley for an initial $2.8 billion, weeks after the Trump ...

Novo is seeking to force Lilly to pull the disputed ads and run corrective ones as the companies compete for dominance in the ...

Novo Nordisk says Eli Lilly’s blockbuster weight-loss comparison became misleading after Wegovy’s dose increased.

Novo Nordisk claims Eli Lilly aired misleading ads comparing the pharma companies' respective weight-loss drugs, Wegovy and ...

Novo Nordisk is also demanding that Eli Lilly pull its ads and pay damages.

Novo Nordisk said Eli Lilly's ads uses outdated research and leave out important information, which could mislead consumers.